Brought to you by:
-
Verified vascular! Quality care in vascular disease
The Society for Vascular Surgery (SVS) and American College of Surgeons (ACS) Vascular Verification Program (Vascular-VP) will be a central focus on the opening day of the 2024 Vascular Annual Meeting (VAM) as the topic of the E. Stanley Crawford Critical Issues Forum. The Crawford Forum, traditionally put together by the SVS president-elect, drills into…
-
CEA vs TCAR: Surgeons should be familiar with both procedures and ‘collaborate as needed’
When it comes to the ongoing debate of carotid endarterectomy (CEA) versus transcarotid artery revascularization (TCAR) in the treatment of carotid artery stenosis, operators should be comfortable and maintain experience with both of these procedures—and “collaborate as needed.” That is the ultimate finding of a registry analysis set to be presented later this week at…
-
VAM 2024: Enhancing clinical practice and patient interaction in CLTI
A key event on informed decision-making in chronic limb-threatening ischemia (CLTI) promises to be a highlight of the 2024 Vascular Annual Meeting (June 19–22). Funded by a grant from the Council of Medical Specialty Societies (CMSS) awarded to the SVS, the event aims to expand physician knowledge and improve clinical confidence in treating CLTI. The breakfast…
-
‘The forgotten stepchild of vascular surgery’: The quest to push forward basic science research in venous disease
The 2024 Venous Symposium (May 8–11) in New York City was highlighted by keynote speaker Peter Pappas, MD, regional medical director and program director of the venous and lymphatic medicine fellowship at the Center for Vein Restoration in Morristown and Union, New Jersey. Pappas spoke about new frontiers in venous and lymphatic disease management while…
-
VAM 2024: Changes to carotid stenting landscape in United States set to be discussed
Sean P. Lyden, MD, chairman of the Department of Vascular Surgery at Cleveland Clinic’s Heart, Vascular and Thoracic Institute in Cleveland, Ohio, will discuss the national coverage determination (NCD) changes passed by the Centers for Medicare & Medicaid Services (CMS) on carotid artery stenting (CAS) during the 2024 Vascular Annual Meeting (VAM). His presentation—part of…
-
The top 10 most popular Vascular Specialist stories of May 2024
In April, the most read stories from Vascular Specialist include new data from the C-GUARDIANS pivotal investigational device exemption (IDE) trial presented at the Leipzig Interventional Course (LINC) 2024 (28–31 May, Leipzig, Germany); recently released randomised data show cyanoacrylate glue performs strongly on patient satisfaction; Karith Foster, chief executive of Inversity Solutions, shares her thoughts…
-
Register for 2024 Vascular Health Step Challenge at VAM
Attending a conference such as the Vascular Annual Meeting (VAM) is a great way to increase step count and get blood flowing, which is why the SVS Foundation is bringing back the Vascular Health Step Challenge at VAM 2024 in Chicago. The first Vascular Health Step Challenge at VAM took place last year in National…
-
SVS Foundation awards announced
The SVS Foundation has announced recipients for the 2023–2024 awards cycle. The slew of awardees is headed by the winner of the S.T. Yao Resident Research Award winner, Kevin D. Mangum, MD, an integrated vascular resident at the University of Michigan in Ann Arbor. His paper, “The STAT3-SETDB2 axis dictates NFkB-mediated inflammation in macrophages during…
-
‘I’m a big fan of firsts’: Nationally renowned speaker on DEI set to headline new SVS keynote
Karith Foster, chief executive of Inversity Solutions, is set to headline the inaugural Society for Vascular Surgery (SVS) Keynote Speaker Series at the 2024 Vascular Annual Meeting (VAM 2024). It starts with a title. For Foster, her keynote begins with an ending: “Finishing the journey to inclusivity through belonging, intention and respect.” The address, which…
-
End of an era: Schanzer and Robinson leave legacy of VAM innovation
As this year’s Society for Vascular Surgery (SVS) Vascular Annual Meeting (VAM) approaches, it marks the end of an era for Andres Schanzer, MD, and William Robinson, MD, who have played integral roles in shaping the event’s trajectory. Schanzer’s leadership as VAM program chair comes to a close after 10 years of being on the…